BioSig Technologies [BSGM] vs Abbott Laboratories [ABT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: BioSig Technologies wins in 5 metrics, Abbott Laboratories wins in 10 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBioSig TechnologiesAbbott LaboratoriesBetter
P/E Ratio (TTM)N/A16.53N/A
Price-to-Book Ratio36.514.53Abbott Laboratories
Debt-to-Equity Ratio0.0126.50BioSig Technologies
PEG Ratio-6.540.45BioSig Technologies
EV/EBITDA-5.7220.59BioSig Technologies
Profit Margin (TTM)0.00%32.43%Abbott Laboratories
Operating Margin (TTM)-211,407.70%19.73%Abbott Laboratories
EBITDA Margin (TTM)N/A19.73%N/A
Return on Equity739.31%30.93%BioSig Technologies
Return on Assets (TTM)-30.45%6.62%Abbott Laboratories
Free Cash Flow (TTM)$-4.76M$6.35BAbbott Laboratories
Dividend YieldN/A1.28%N/A
1-Year Return1,060.47%17.14%BioSig Technologies
Price-to-Sales Ratio (TTM)11,976.445.32Abbott Laboratories
Enterprise Value$153.48M$235.76BAbbott Laboratories
EV/Revenue Ratio11,806.495.47Abbott Laboratories
Gross Profit Margin (TTM)N/A56.44%N/A
Revenue per Share (TTM)$0$25Abbott Laboratories
Earnings per Share (Diluted)$-0.53$7.97Abbott Laboratories
Beta (Stock Volatility)N/A0.71N/A
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

BioSig Technologies vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
BioSig Technologies5.72%-2.16%-13.37%51.21%436.56%256.43%
Abbott Laboratories-0.33%2.10%6.09%-0.79%-2.16%16.36%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
BioSig Technologies1,060.47%-53.80%-93.34%-86.78%-94.30%-94.30%
Abbott Laboratories17.14%29.54%19.14%186.83%452.07%515.10%

Performance & Financial Health Analysis: BioSig Technologies vs Abbott Laboratories

MetricBSGMABT
Market Information
Market Cap i$155.69M$229.31B
Market Cap CategoryMicro capMega cap
10 Day Avg. Volume i829,5906,185,250
90 Day Avg. Volume i1,352,0307,383,993
Last Close$4.99$132.00
52 Week Range$0.23 - $14.11$110.68 - $141.23
% from 52W High-64.64%-6.54%
All-Time High$124.30 (May 11, 2020)$142.60 (Dec 27, 2021)
% from All-Time High-95.99%-7.43%
Growth Metrics
Quarterly Revenue Growth-1.00%0.07%
Quarterly Earnings Growth-1.00%0.37%
Financial Health
Profit Margin (TTM) i0.00%0.32%
Operating Margin (TTM) i-2,114.08%0.20%
Return on Equity (TTM) i7.39%0.31%
Debt to Equity (MRQ) i0.0126.50
Cash & Liquidity
Book Value per Share (MRQ)$-0.12$29.05
Cash per Share (MRQ)$0.09$4.18
Operating Cash Flow (TTM) i$-4,356,000$9.04B
Levered Free Cash Flow (TTM) i$101.23M$5.92B
Dividends
Last 12-Month Dividend Yield iN/A1.28%
Last 12-Month Dividend iN/A$1.69

Valuation & Enterprise Metrics Analysis: BioSig Technologies vs Abbott Laboratories

MetricBSGMABT
Price Ratios
P/E Ratio (TTM) iN/A16.53
Forward P/E i-6.5425.53
PEG Ratio i-6.540.45
Price to Sales (TTM) i11,976.445.32
Price to Book (MRQ) i36.514.53
Market Capitalization
Market Capitalization i$155.69M$229.31B
Enterprise Value i$153.48M$235.76B
Enterprise Value Metrics
Enterprise to Revenue i11,806.495.47
Enterprise to EBITDA i-5.7220.59
Risk & Other Metrics
Beta iN/A0.71
Book Value per Share (MRQ) i$-0.12$29.05

Financial Statements Comparison: BioSig Technologies vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BSGMABT
Revenue/Sales i$0$10.36B
Cost of Goods Sold iN/A$4.47B
Gross Profit iN/A$5.89B
Research & Development i$19,000$716.00M
Operating Income (EBIT) i$-20.37M$1.69B
EBITDA i$-19.81M$2.66B
Pre-Tax Income i$-20.37M$1.78B
Income Tax i$0$453.00M
Net Income (Profit) i$-20.37M$1.33B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BSGMABT
Cash & Equivalents i$3.73M$6.53B
Total Current Assets i$3.99M$23.15B
Total Current Liabilities i$1.68M$13.00B
Long-Term Debt iN/A$12.74B
Total Shareholders Equity i$2.74M$49.06B
Retained Earnings i$-258.16M$47.72B
Property, Plant & Equipment i$814,000N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BSGMABT
Operating Cash Flow i$-490,000$1.42B
Capital Expenditures iN/A$-484.00M
Free Cash Flow i$-1.12M$933.00M
Debt Repayment iN/A$-1.00B
Common Stock Repurchase iN/A$-280.00M

Short Interest & Institutional Ownership Analysis

MetricBSGMABT
Shares Short i1.35M18.33M
Short Ratio i0.902.44
Short % of Float i0.05%0.01%
Average Daily Volume (10 Day) i829,5906,185,250
Average Daily Volume (90 Day) i1,352,0307,383,993
Shares Outstanding i17.24M1.73B
Float Shares i24.64M1.73B
% Held by Insiders i0.29%0.01%
% Held by Institutions i0.29%0.81%

Dividend Analysis & Yield Comparison: BioSig Technologies vs Abbott Laboratories

MetricBSGMABT
Last 12-Month Dividend iN/A$1.69
Last 12-Month Dividend Yield iN/A1.28%
3-Year Avg Annual Dividend iN/A$1.92
3-Year Avg Dividend Yield iN/A0.49%
3-Year Total Dividends iN/A$5.77
Ex-Dividend DateN/AJan 15, 2025